DIA 2017 Editor’s Take – DrugDev

Thought Leader:

Eric Delente, President, New Patient Solutions, DrugDev

July 21, 2017      

Eric Delente discusses how eConsent differs from the traditional informed consent procedures, the barriers keeping some organizations from converting to digital, lessons learned regarding eConsent, and how eConsent can make monitoring easier.

For more information please visit www.drugdev.com/.

Post a Comment

You must be logged in to post a Comment.

FEEDBACK